12:00 AM
Sep 27, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

PI-88: Began Phase I study

Progen Industries Ltd. (ASX:PGL; PGLAF), Brisbane, Australia
Product: PI-88
Business: Cancer...

Read the full 44 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >